Barcelona, Catalonia, Spain
Medical Science Liaison (MSL) with a PhD in Molecular Oncology, experienced across Immunology, Dermatology, and Oncology. Skilled in KOL engagement, scientific exchange, launch readiness, evidence generation (RWE/IIR), and cross-functional collaboration, contributing to impactful medical strategies and improved patient outcomes. Passionate about translating complex scientific evidence into actionable insights that bridge research and clinical practice. I enjoy building trusted relationships with healthcare professionals, collaborating with cross-functional teams, and driving initiatives that combine science, strategy, and patient-centered care. Selected Highlights: Strengthened Incyte's scientific leadership through pre-launch initiatives, KOL engagement, and strategic medical collaboration. Core Expertise: Medical Science Liaison | Medical Affairs | Immunology | Dermatology | Oncology | KOL Engagement | Scientific Exchange | Launch Readiness | Evidence Generation (RWE/IIR) | Cross-functional Collaboration | Medical Strategy | Patient Impact
Summary / Responsibilities - Define and execute medical strategies supporting pre-launch and launch readiness across Immunology and Oncology. - Engage with KOLs, facilitate scientific exchange, and contribute to evidence generation (RWE/IIR). - Collaborate cross-functionally with Medical Affairs, Marketing, Market Access, and Clinical Operations. Key Achievements - Acted as interim Medical Advisor for 5 months, leading medical strategy and cross-functional coordination. - Led onboarding and scientific training for the new sales force, accelerating performance to achieve 100% of sales targets in first month. - Coordinated >50 medical contracts, supporting high-impact symposia, investigator meetings, and scientific initiatives. - Strengthened MSL field readiness through competitor landscape analysis and clinical trial training, contributing to engagement of >10 KOLs in Phase III studies. - Proposed and implemented strategic medical initiatives adopted by the Brand Team, influencing national medical strategy.
- Led translational oncology research using advanced 3D human organoid models, an FDA-validated system supporting therapies now in Phase II trials. - Managed projects with >€1M in competitive funding (ISCIII), coordinating multidisciplinary teams and delivering high-impact scientific outcomes. - Published in high-impact journals (e.g., Cell Death & Disease, IF 9.6, Q1) and received the Most Relevant Publication 2024 award (IIBB-CSIC). - Mentored and trained PhD students, several of whom later obtained competitive grants and fellowships. - Collaborated with oncologists at Hospital Universitario La Paz to support grant applications and ensure project continuity. - Presented at international congresses, gaining recognition from global KOLs; featured in national media for translational and societal impact.
- Designed and executed a PhD project on vitamin D’s role in tumor progression using 3D organoid models. - Developed analytical and problem-solving skills, integrating molecular biology and translational oncology approaches. - Collaborated with academic KOLs and contributed to peer-reviewed publications and international conferences. - Promoted scientific outreach through seminars and educational initiatives.
- Conducted GLP-compliant research on Fanconi Anemia in a translational research setting. - Supported experimental design and contributed to a peer-reviewed publication. - Developed technical and analytical skills applied to rare disease research.